
Magaldrate is a premium-grade, high-purity hydrated magnesium aluminate complex carrying CAS number 7497-87-6. Refined under strict pharmaceutical quality compliance, this active pharmaceutical ingredient (API) exhibits exceptional acid-neutralizing capacity in the development of gastrointestinal medications. Therefore, it provides rapid and sustained relief in sensitive medicinal formulations. Consequently, it serves as an ideal core choice for specialized antacid suspensions, tablet formulations, and modern pharmaceutical synthesis processes globally.
Excellent buffer capacity and outstanding acid-neutralizing efficiency provide a distinct operational edge. This advantage is crucial when engineering modern high-performance gastrointestinal formulations. This active pharmaceutical solid operates by facilitating the systemic modification of targeted gastric acid pathways. Thus, it successfully enhances the therapeutic profiling of targeted pharmaceutical matrices. It supplies the exact chemical mechanisms required to induce rapid synthetic steps. As a consequence, it does this without altering raw mass density uniformity.
It assists formulation engineers in maintaining strict active concentration uniformity. This balance is critical across high-speed pharmaceutical synthesis operations and continuous filling lines. Hence, it mitigates trace impurity risks within automated volumetric dosing machinery. For instance, specialized production facilities incorporate this refined powder. It acts as a core active component in targeted dyspepsia management and specialized treatment cycles. Consequently, it maximizes the technical throughput of automated formulation machinery. Consequently, Zyntex coordinates clean-room synthesis paths to eliminate downstream moisture-induced alterations from your factory schedule.
In addition to this, Zyntex coordinates climate-controlled logistics for manufacturing operations. This service supports advanced pharmaceutical synthesis centers globally. The compound maintains its refined chemical structure under strict storage parameters. Therefore, it prevents degradation during automated mechanical blending steps. It advances contemporary drug engineering by providing a thoroughly analyzed, highly predictable raw material.
This high-purity active compound delivers crucial technical value within these four primary sectors:
Primary API for antacid suspensions and chewable tablets.
Reference material for gastric acid neutralization kinetics.
Highly purified additive for customized pharmaceutical drug manufacturing.
Reference material for validating pharmaceutical ingredient performance.
| Parameter | Standard Value |
|---|---|
| Product Name | Magaldrate |
| Assay / Purity | Pharmacopoeial Grade |
| Appearance | White, fine powder |
| CAS Number | 7497-87-6 |
✅ SAFETY & HANDLING (Low Hazard / Non-Toxic): Magaldrate is considered a low-hazard pharmaceutical substance. Handling: Use standard laboratory protective equipment (gloves and safety glasses) to prevent dust inhalation or eye contact. Storage: Keep in a tightly closed, cool, and dry container. Stable under normal environmental conditions. Review the full Safety Data Sheet (SDS) for specific facility protocols.